Abstract
We reviewed the use of oral dichloroacetate (DCA) in the treatment of children with congenital lactic acidosis caused by mutations in the pyruvate dehydrogenase complex (PDC). The case histories of 46 subjects were analyzed with regard to diagnosis, clinical presentation and response to DCA.
DCA decreased blood and cerebrospinal fluid lactate concentrations, and was generally well tolerated. DCA may be particularly effective in children with PDC deficiency by stimulating residual enzyme activity and, consequently, cellular energy metabolism.
A controlled trial is needed to determine the definitive role of DCA in the management of this devastating disease.
Poll Are Provider Comments in Your Medical Records Affecting Your Care?
Lucie's Surprisingly Simple Road to RecoveryYears of searching results in a simple and inexpensive pathway to recovery
"Chronic Fatigue Gone" - After 16 Years Jason Figures It OutEclectic alternative health treatments including hydrogen peroxide and ketamine prove helpful
Very Severely Ill "ME/CFS" Patient Gets a New Diagnosis, New Treatment Approach & Major ImprovementFormer ER Doc gets a CIRS diagnosis and massive improvement under Dr. Heyman's Care
![ME/CFS lecture | Dr Nancy Klimas | 2011 [Chronic Fatigue Syndrome / SEID / New Zealand] - YouTube](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
